The weight loss and insulin sensitivity improvements associated with orforglipron would be expected to significantly reduce the risk of progression from prediabetes to overt type 2 diabetes
Primary outcomes include measures of cognition, function, safety, and tolerability
You complete a health intake, message a licensed provider, and, if approved, receive medication and support delivered to your door
This is the question we hear most right now, so here is what is known and what is not
This is why Klinic does not prescribe Ozempic
When used thoughtfully, this combination offers many of the same therapeutic benefits as Qsymia while providing greater flexibility in managing each medications contribution to weight loss